The Changing Face (to-Face) of Pharmaceutical Sales

Today's post comes from ePharma Summit speaker Andrew Watson, Associate Vice President, Sales & Marketing at Wockhardt USA. He will be presenting The Doctor Will “See” You: Bridging the Gap Between Doctors and Pharma on Tuesday, February 11. The face of pharmaceutical sales continues to change. Today’s pharmaceutical sales representatives face an ever-changing medical office dynamic: A growing percentage of rep visits end without the sales representative ever getting face-to-face with a physician, and an increasing number of doctor offices are designated “no see.” Nonetheless, healthcare professionals continue to want fresh, relevant scientific data enabling them to deliver the best possible care to their patients. By leveraging the latest technology, virtual sales representatives are able to communicate with difficult-to-reach healthcare professionals and provide them with access to the same product information, insurance data, and samples as their traditional colleagues. At the upcoming ePharma Summit, I’ll be speaking on vRep SM --an innovative program that allows a pharmaceutical sales representative the ability to demonstrate—face-to-face—the latest product information without intruding on a busy medical office. How It WorksThe vRep experience begins with the sales team contacting target healthcare providers, identified through a sales target list. Once a representative speaks with a healthcare provider, they schedule an appointment that works with ...
Source: ePharma Summit - Category: Medical Marketing and PR Tags: #epharma ePharma Summit Pharmaceutical Sales Virtual Pharma Sales Reps Source Type: blogs